Linda C. Hogan

Linda C. Hogan appears in our data through filings on CoLucid Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 35 filings; the first trade dates from 6 September 2016 and the latest from 5 January 2017.

The open-market record consists of 18 sales worth €1.2M, with no purchase. Besides market trades, the filings include 17 option exercises. Since January 2017: no purchases and 5 sales on the market.

On 5 January 2017 came the latest disclosure, an option exercise for €4,633 in CoLucid Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.